Activities that will be undertaken by the new ECRIN-M3 Network integrate and synergise efforts of 14 research groups from 4 leading institutions in Europe (as well as in Africa and South America) on MBL.

The multidisciplinary clinical, scientific, and translational teams, the local infra-structures and technological expertise, together with previous and ongoing collaborations in the field of MBL and CLL, plus external collaborations, make the ideal environment for a strong and very successful programme and Network, with great potential for medium-to-long term sustainability.